Selvigaltin

Selvigaltin · Roswell Park Cancer Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Selvigaltin, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma [Phase 1]